JAMA Dermatology Publishes Data Showing RINVOQ® Achieved Superiority Versus DUPIXENT® for Primary and All Ranked Secondary Endpoints in Phase 3b Head-to-Head Study in Adults with Atopic Dermatitis
Medical Device Investing Bronstein, Gewirtz & Grossman, LLC Notifies Shareholders of Bausch Health Companies Inc. Investigation
BioHarvest Sciences Inc. Announces a CAD 4 Million Private Placement to Accelerate Its Cannabis Development Program and Production Capacity in Israel
Perimeter Medical Imaging AI to Participate in the 6th Annual Needham Virtual Med Tech & Diagnostics 1x1 Conference
Wellteq Partners With LifeSpeak to Enhance Targeted Wellness Education and Expand Suite of Mental Health Programs
BioNTech Completes Acquisition of Kite's Neoantigen TCR Cell Therapy R&D Platform and Manufacturing Facility in Gaithersburg, Maryland
Medical Device Investing Health Canada Approves ARAZLO Lotion, 0.045%, First Such Lotion Treatment For Acne Vulgaris
Pharmaceutical Investing Pfizer Announces Positive Top-Line Results from Phase 2b/3 Trial of Ritlecitinib in Alopecia Areata
Medical Device Investing SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Bausch Health Companies Inc. - BHC
Cloud DX Announces the Date of Its Second Quarter Investor Update and Earnings Call, Retention of Market Maker and Retention of IR Specialist
Radiopharm Theranostics Accelerates 177Lu-RAD204 Phase 1 Dose Escalation Clinical Trial Based on Positive Recommendation from Data Safety and Monitoring Committee
